Piper Jaffray Sees Significantly More Downside Risk, Versus Upside Potential to Valeant's (VRX) 2016 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. PRIM
2. ABBV
3. IBM
4. META
5. DPZ
6. DFTX
7. CNC
8. KFY
9. SPY
10. MU

Go back to Piper Jaffray Sees Significantly More Downside Risk, Versus Upside Potential to Valeant's (VRX) 2016 Guidance

Valeant Pharma (VRX) Short Interest Surges 56% - Guggenheim

April 11, 2016 5:42 PM EDT

In analyzing the latest short interest data for the Specialty Pharmaceutical sector, Guggenheim's Louise Chen notes that Valeant Pharma (NYSE: VRX) short interest rose 56.1% - the largest increase in the sector.

Valeant Pharma short interest was at 18,021,306 shares as of 03/31/2016, versus 11,548,303... More